3rd Quarter - Report

CAPITOL HILL STRATEGIES, LLC for PHRMA

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 1548, Pathway for Biosimilars Act of 2009 H.R. 1427, Promoting Innovation and Access to Life-saving Medicines Act H.R. 2502, Comparative Effectiveness Research Act of 2009 S. 1213, Patient-Centered Outcomes Research Act of 2009

LobbyistCovered position, as disclosed
CHARLES M BRAIN Asst. to the President, Dp.Chief Staff W&M Cmte
BEAU` SCHUYLER LD-CongTanner, LD-CongMcIntyre,SA-CongRose
A. J. WOJCIAK Senior Legislative Asst., Cong. Earl Pomeroy

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1548 (111th), H.R. 1427 (111th), S. 1213 (111th), H.R. 2502 (111th)

Medicare/Medicaid MMM

S. ____, America's Healthy Future Act of 2009 (Comparative Effectiveness Research, Part D provisions, 340B provisions) S. 1679, the Affordable Health Choices Act (Comparative Effectiveness Research, Part D provisions, 340B provisions, Follow on biologics) H.R. 3200, America's Affordable Health Choices Act of 2009

LobbyistCovered position, as disclosed
CHARLES M BRAIN Asst. to the President, Dp.Chief Staff W&M Cmte
BEAU` SCHUYLER LD-CongTanner, LD-CongMcIntyre,SA-CongRose
A. J. WOJCIAK Senior Legislative Asst., Cong. Earl Pomeroy

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1679 (111th), H.R. 3200 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.